WhaleWatch logoWhaleWatch
Sign inStart for ₹1
Smart Money Alert
Glenmark Pharmaceuticals Limited logo

Glenmark Pharmaceuticals Limited

DecreasedQuarterly
GLENMARKHealthcareMarket Cap₹75K Cr
Stake
1.27% → 1.15%
Holding
32.59 L shares
Change
−3.20 L shares
As of
Jun 2026
Since alert+18.4%₹2,235.50 → ₹2,648.00
Nifty 50+6.0%
UTI Mutual Fund
UTI Mutual Fund
Mutual Fund
The move

UTI Mutual Fund decreased its stake in Glenmark Pharmaceuticals from 1.27% to 1.15%, selling 3,19,539 shares.

About Glenmark Pharmaceuticals Limited
+ FollowVisit stock

A global research-led pharmaceutical company, Glenmark operates across generics, specialty, and over-the-counter business segments with a presence in more than 80 countries worldwide. The company develops and manufactures pharmaceutical products serving patients across multiple therapeutic areas including oncology, dermatology, and respiratory care. Its distinctive strength lies in combining generic drug manufacturing capabilities with specialty pharmaceutical development and maintaining a robust international distribution network across developed and emerging markets.

About UTI Mutual Fund
+ FollowVisit investor

India's oldest and most storied asset manager, founded in 1963 as the Unit Trust of India under an Act of Parliament. Now manages over Rs 3.5 lakh crore with backing from four public sector institutions: LIC, SBI, Bank of Baroda, and Punjab National Bank. CIO Vetri Subramaniam is a long-term compounder with a consistent quality tilt and clear articulation of process.

Get the next move the moment it happens.
Follow UTI Mutual Fund and Glenmark Pharmaceuticals Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
Explore
Glenmark Pharmaceuticals Limited shareholdersUTI Mutual Fund's portfolioAll investorsAll stocks
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Glenmark Pharmaceuticals Limited
More moves in Glenmark Pharmaceuticals Limited
UTI Mutual FundExited
UTI Mutual Fund is no longer listed among the major shareholders of Glenmark Pharmaceuticals Limited, having either completely exited or trimmed its previous 1.15 percent stake to somewhere below the 1 percent reporting threshold.
19 Oct 2026
Read more
Invesco Mutual FundDecreased
Invesco Mutual Fund decreased its stake in Glenmark Pharmaceuticals Limited from 2.20% to 1.97%, selling 6,44,659 shares.
19 Oct 2026
Read more
HDFC Mutual FundDecreased
HDFC Mutual Fund reduced its stake in Glenmark Pharmaceuticals from 6.22% to 6.01%, selling 6,13,353 shares.
19 Oct 2026
Read more
Government Pension Fund Global (Norway)Decreased
Government Pension Fund Global (Norway) reduced its stake in Glenmark Pharmaceuticals from 3.89% to 3.83%, selling 1,69,845 shares.
19 Oct 2026
Read more
Amansa HoldingsDecreased
Amansa Holdings trimmed its stake in Glenmark Pharmaceuticals Limited from 2.22% to 2.04%, selling 4,80,904 shares.
19 Oct 2026
Read more
See all moves
UTI Mutual Fund
More moves by UTI Mutual Fund
2newest moves
Members only
Xxxxxx Xxxxxxxxxxxx xxxxxxx xxx xxxxx
Xxxxxxxx Xxxxxxxxxxxx xxxxx xx xxxxxxx
Unlock all 2 moves
Metropolis Healthcare LimitedDecreased
UTI Mutual Fund trimmed its stake in Metropolis Healthcare from 3.87% to 2.81%, selling 21,87,399 shares.
METROPOLIS22 Oct 2026
Read more
Coforge LimitedIncreased
UTI Mutual Fund increased its stake in Coforge Limited from 1.95% to 2.03% by purchasing 3,37,043 shares.
COFORGE22 Oct 2026
Read more
Crompton Greaves Consumer Electricals LimitedIncreased
UTI Mutual Fund increased its stake in Crompton Greaves Consumer Electricals Limited from 3.68% to 3.74%, purchasing 3,57,501 shares.
CROMPTON21 Oct 2026
Read more
See all moves